Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd has demonstrated a marked shift in technical momentum, upgrading from a mildly bullish to a bullish trend across multiple timeframes. This transition is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting a positive outlook for this micro-cap pharmaceutical stock amid robust price performance relative to the broader market.

Kwality Pharmaceuticals Ltd has demonstrated a significant shift in price momentum and technical indicators, signalling a cautiously optimistic outlook for this micro-cap player in the Pharmaceuticals & Biotechnology sector. With a recent upgrade in its Mojo Grade from Hold to Buy and a robust 4.09% gain on the day, the stock is attracting renewed investor interest amid mixed technical signals.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Surging past the Rs 1780 mark, Kwality Pharmaceuticals Ltd has achieved a new 52-week high on 20 Apr 2026, extending its remarkable one-year rally of 106.59% against a flat Sensex. This milestone reflects a powerful confluence of technical momentum and sustained earnings growth that has propelled the stock well above its key moving averages.

Kwality Pharmaceuticals Ltd has reached a significant milestone by touching an all-time high price of Rs.1782 on 20 April 2026, marking a remarkable achievement in the company’s market journey within the Pharmaceuticals & Biotechnology sector.

Surging past its previous peaks, Kwality Pharmaceuticals Ltd touched a new 52-week high of Rs 1760 on 17 Apr 2026, marking a remarkable rally from its 52-week low of Rs 666. This milestone caps a sustained period of price momentum, underpinned by a confluence of bullish technical indicators and steady fundamental performance.

Extending its winning streak to four sessions, Kwality Pharmaceuticals Ltd surged 4.28% on 17 Apr 2026 to close at Rs 1,751.65, just 0.67% above its 52-week high. This rally comes amid a broader outperformance against the Sensex, which gained a modest 0.40% on the same day.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Kwality Pharmaceuticals Ltd has reached a new all-time high on 16 Apr 2026, reflecting a remarkable phase of growth and robust performance in the Pharmaceuticals & Biotechnology sector. The stock’s surge underscores the company’s sustained financial strength and market resilience.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s performance and prospects.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Kwality Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.1740 on 12 Mar 2026, underscoring a remarkable period of sustained growth and robust financial performance.

Kwality Pharmaceuticals Ltd has surged to a fresh 52-week and all-time high of Rs.1740, marking a significant milestone in its market performance. This achievement underscores the stock’s robust momentum amid a challenging broader market environment.

Kwality Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week and all-time high of Rs.1674 today, marking a notable surge in its stock price amid a challenging broader market environment.

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with the latest insights into its performance and outlook.